Responding to a surge in tough-to-treat gonorrhea, the Centers for Disease Control and Prevention has stopped recommending a group of related antibiotics for the disease. Now, only one class of antibiotic—called cephalosporins—remains on the CDC’s list of treatments for the second-most-common sexually transmitted disease in the United States.
“This is a bad bugs–no drugs issue,” says Henry Masur, president of the Alexandria, Va.–based
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.